In Utero Repair of Myelomeningocele: Atosiban Versus Terbutaline

NCT04468568 · clinicaltrials.gov ↗

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Myelomeningocele
Terbutaline Adverse Reaction
Pregnancy; Malformation Central Nervous System

Interventions

DRUG: Atosiban
DRUG: Terbutaline

Sponsor

University of Sao Paulo General Hospital